The future is bedside-to-bench: "Systemic comparison (of immunotherapy irAEs) with canonical forms of (inflamm arthritis)... may shed novel insights into the development of IA more broadly and identify common mechanisms and targets for therapy" @cappelliMD https://t.co/zYZyUFx8KU